Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Disease Markers
Volume 2016, Article ID 2138627, 12 pages
http://dx.doi.org/10.1155/2016/2138627
Review Article

Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer

Medical Oncology Department, Hospital Universitario Doce de Octubre and Centro Nacional de Investigaciones Oncológicas (CNIO), 28041 Madrid, Spain

Received 31 March 2016; Accepted 12 June 2016

Academic Editor: Monica Neagu

Copyright © 2016 Ángela Marrugal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • Spiros A. Vlahopoulos, “Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode,” Cancer Biology and Medicine, vol. 14, no. 3, pp. 254–270, 2017. View at Publisher · View at Google Scholar
  • Estela Maria Silva, Vânia Sammartino Mariano, Paula Roberta Aguiar Pastrez, Miguel Cordoba Pinto, António Gil Castro, Kari Juhani Syrjanen, and Adhemar Longatto-Filho, “High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer,” Plos One, vol. 12, no. 7, pp. e0181125, 2017. View at Publisher · View at Google Scholar
  • Niklas Wulkow, Jan Vybiral, Christof Schütte, Tim O.F. Conrad, Martin Genzel, Nada Cvetkovic, Alexander Leichtle, and Gitta Kutyniok, “Sparse Proteomics Analysis - a compressed sensing-based approach for feature selection and classification of high-dimensional proteomics mass spectrometry data,” BMC Bioinformatics, vol. 18, no. 1, 2017. View at Publisher · View at Google Scholar
  • Maulik Patel, Sandip Pravin Patel, and Razelle Kurzrock, “Combinations of Genomically and Immune-Targeted Therapies in Early-Phase Clinical Trials,” Early Phase Cancer Immunotherapy, pp. 243–280, 2017. View at Publisher · View at Google Scholar
  • Oyunbileg von Stackelberg, and Hans-Ulrich Kauczor, “Lung Cancer Screening,” 2017. View at Publisher · View at Google Scholar
  • Ángela Marrugal, Laura Ojeda, Luis Paz-Ares, Sonia Molina-Pinelo, and Irene Ferrer, “Corrigendum to “Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer”,” Disease Markers, vol. 2018, pp. 1–1, 2018. View at Publisher · View at Google Scholar
  • Jing Zhang, Xiangqian Guan, Naixin Liang, and Shanqing Li, “Estrogen-related receptor alpha triggers the proliferation and migration of human non-small cell lung cancer via interleukin-6,” Cell Biochemistry and Function, 2018. View at Publisher · View at Google Scholar
  • Zheng Wang, and Xiaoju Zhang, “Single Cell Proteomics for Molecular Targets in Lung Cancer: High-Dimensional Data Acquisition and Analysis,” Single Cell Biomedicine, vol. 1068, pp. 73–87, 2018. View at Publisher · View at Google Scholar
  • Boris Sepesi, Yuanqing Ye, Kyle G. Mitchell, Liren Zhang, Jianchun Gu, Lin Ji, Mara B. Antonoff, Wayne L. Hofstetter, David C. Rice, Reza J. Mehran, Garrett L. Walsh, Ara A. Vaporciyan, Stephen G. Swisher, Jack A. Roth, and Xifeng Wu, “Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients,” The Journal of Thoracic and Cardiovascular Surgery, 2018. View at Publisher · View at Google Scholar